Akamai (AKAM) Q3 2026 Earnings Call Transcript

Akamai reported Q3 2026 revenue of $1.122 billion, up 6% year over year, while non-GAAP EPS fell 5% to $1.77 and operating margin declined 6 percentage points to 25%. Management cited $14 billion in multiyear cloud infrastructure commitments, including Anthropic's $11.6 billion, seven-year deal, and forecast 2027 cloud infrastructure revenue of $1.1 billion–$1.3 billion and total revenue growth of 17%–22% in constant currency. Supply-chain and data-center delays shift about $30 million of revenue from Q4 2026 into 2027; Q4 CapEx is projected at $2.445 billion–$2.645 billion, largely for component purchases supporting the contract ramp.

Analysis

The key underwriting question is not whether demand exists, but whether contracted revenue converts into cash returns on schedule. Near-term, colocation and infrastructure costs precede revenue, so the sharp CapEx step-up and margin trough can outweigh headline backlog growth; a revenue delay may be timing-only for contract value yet still pressure quarterly cash conversion and investor confidence. The 13% after-tax IRR is management’s estimate, not independently validated, and is most exposed to utilization, hardware life, and cost assumptions. CPU reuse across security and compute could improve asset economics, but seven-year commitments also create technology and workload-mix risk if inference shifts toward accelerators.

Akamai gains leverage from its security relationships and distributed footprint; hyperscalers and GPU-heavy neocloud providers may be less suited to latency-sensitive, CPU-oriented workloads, while colo and memory suppliers retain bargaining power when capacity is tight. Conversely, prioritizing CIS over low-return delivery business may stabilize returns but limits the legacy segment’s growth contribution. The Anthropic commitment is a meaningful concentration within announced bookings, despite the broader customer pipeline.

Over 1–3 months, watch CIS revenue timing, Q4 margin, and CapEx execution. Over 6–18 months, proof of the 2027 ramp and operating cash flow matters more than additional bookings. Thesis weakens if CIS misses its guided range, deployment delays recur, margins fall more than management’s stated near-term pressure, or funding needs threaten investment-grade access. With no valuation or share-price data, the growth outlook alone does not establish an attractive entry.

Key Decisions for Investors

• Avoid chasing the backlog headline; treat AKAM as a staged execution opportunity and wait for evidence that deployments convert to recognized CIS revenue and cash flow.
• Monitor Q4 and 2027 quarterly disclosures for CIS revenue versus the $1.1–$1.3 billion 2027 guide, CapEx, operating margin, and cash from operations. Repeated delays or a downward guide revision falsify the execution thesis.
• For a relative-value watchlist, compare AKAM with GPU-heavy AI infrastructure providers: Akamai may benefit if enterprise inference demand favors distributed CPU capacity, but do not assume direct substitution without workload and utilization evidence.
• Track the remaining hardware procurement, colocation cost escalators, and the 2027 convertible maturity; assess financing and rating implications if cash deployment or leverage diverges from management’s plan.
• Do not underwrite the $9 billion Anthropic option or management’s target returns as base-case value until contract economics, utilization, and realized margins are verified.